ClinicalTrials.Veeva

Menu

Lactobacillus Rhamnosus GG in the Middle Ear and Adenoid Tonsil

H

Helsinki University Central Hospital (HUCH)

Status

Completed

Conditions

Acute Otitis Media
Upper Respiratory Infection

Treatments

Dietary Supplement: Lactobacillus rhamnosus GG

Study type

Interventional

Funder types

Other

Identifiers

NCT02110732
HelsinkiUCH

Details and patient eligibility

About

The purpose of this study is to evaluate the effect of oral administration of probiotic Lactobacillus rhamnosus GG in middle ear and adenoid tonsil.

Enrollment

40 patients

Sex

All

Ages

1 to 5 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • recurrent otitis media
  • secretory otitis media
  • chronic rhinitis
  • recurrent sinusitis

Exclusion criteria

  • significant illness

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

40 participants in 2 patient groups, including a placebo group

Lactobacillus rhamnosus GG
Active Comparator group
Description:
Lactobacillus rhamnosus GG 8-9 x 10 -9 pmy 2x2 for 3 weeks
Treatment:
Dietary Supplement: Lactobacillus rhamnosus GG
Crystalline cellulose
Placebo Comparator group
Description:
Crystalline cellulose
Treatment:
Dietary Supplement: Lactobacillus rhamnosus GG

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems